KCM
Knoll Capital Management Portfolio holdings
AUM
$141M
This Quarter Return
+1.9%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$254M
AUM Growth
+$254M
(-1.1%)
Cap. Flow
+$3.57M
Cap. Flow
% of AUM
1.41%
Top 10 Holdings %
Top 10 Hldgs %
99.59%
Holding
16
New
1
Increased
3
Reduced
2
Closed
2
Top Buys
1 |
Theriva Biologics
TOVX
|
$2.98M |
2 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$1.05M |
3 |
Arcturus Therapeutics
ARCT
|
$665K |
4 |
AMPE
Ampio Pharmaceuticals Inc.
AMPE
|
$60K |
Top Sells
1 |
NRX
NEPHROGENEX INC COM
NRX
|
$626K |
2 |
NWBO
Northwest Biotherapeutics, Inc. Common stock
NWBO
|
$337K |
3 |
Inovio Pharmaceuticals
INO
|
$184K |
4 |
Cellectar Biosciences
CLRB
|
$33K |
Sector Composition
1 | Healthcare | 12.13% |